Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002052113-25-002477·Applied Therapeutics, Inc.
Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock · CUSIP: 03828A101
Event date: 2025-06-30
- Filing-level shares
- 5,219,475
- Percent of class
- 3.7%
- BlackRock, Inc.
Shares: 5,219,475 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-002477
- Form type
- SCHEDULE 13G/A
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- Jul 16, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership